Yamamoto, Y., Kawashima, A., Kashiwagi, E., & Ogata, K. A Jehovah’s Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions. Wiley.
Chicago Style (17th ed.) CitationYamamoto, Yumi, Akihito Kawashima, Eri Kashiwagi, and Kiyoyuki Ogata. A Jehovah’s Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions. Wiley.
MLA (9th ed.) CitationYamamoto, Yumi, et al. A Jehovah’s Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions. Wiley.